News
3 Things About Medtronic That Smart Investors Know
Medtronic (NYSE: MDT) is a massive business that's changing rapidly now to keep up with shifts in its markets and an evolving global economy -- all of which can make it a bit difficult for observers
This FDA Nod Is a Game Changer for Patients: Could It Equal Billions for Vertex Pharmaceuticals?
Vertex Pharmaceuticals (NASDAQ: VRTX) is already a rock star in the world of cystic fibrosis (CF) treatment. The company's drugs have been life-changing for children and adults living with the
2 Cathie Wood Stocks That Can Get You Through Any Recession
Economists at the U.S. Federal Reserve recently uttered the dreaded "R" word. They are now predicting a recession will come later this year. Investors have been bracing for this possibility for a
Why CRISPR Therapeutics Stock Is on Fire Today
Shares of the developmental gene-editing company CRISPR Therapeutics (NASDAQ: CRSP) were up by 12.4% on sky-high volume as of 1:46 p.m. ET Tuesday afternoon. The big gain came in response to the bio
EQS-News: Carl Zeiss Meditec achieves double-digit growth in first half year of 2022/23 with declining earnings
2 Top Healthcare Stocks Defying the Bear Market
Eli Lilly (NYSE: LLY) and Merck (NYSE: MRK) have seen their shares rise by over 17% and 5%, respectively, this year while the S&P 500 Health Care Sector Index has dropped 1.7%. What's interesting
Is Medtronic Stock a Buy Now?
Medtronic (NYSE: MDT) is on a roll in more than one way. The medical device giant is beating the S&P 500 since the start of 2023. The company also continues to strengthen its portfolios, winning
1 Soaring Growth Stock That's Still an Unbeatable Bargain
Are you looking for underappreciated growth stocks that can deliver big gains? Try starting your search in the rapidly growing industry for minimally invasive cosmetic procedures.
The global market
1 Relatively Safe Dividend Growth Stock to Buy Hand Over Fist Right Now
If you can buy high-quality dividend stocks when other investors sour on them, you can plant the seeds for robust returns in the future. And that's exactly why it might be worth buying shares of
Looking for Steady, Passive Income? Buy AbbVie Stock
Dividend growth investing revolves around selecting only the most reliable businesses for your portfolio. This can be measured by consecutive years of dividend growth.
With 51 consecutive years of
Better Gene Sequencing Stock: Illumina vs. Bionano Genomics
Illumina (NASDAQ: ILMN) and Bionano Genomics (NASDAQ: BNGO) might both make gene sequencing devices, but as investments the two couldn't be more different. Whereas Bionano is a new entrant to the
Why Illumina Fell 11.6% in April
Shares of Illumina (NASDAQ: ILMN) fell by 11.6% in April, according to data provided by S&P Global Market Intelligence.
The fall means that shares of the gene-sequencing company have only inched up
3 Great Income Stocks That Retirees Should Love
Most Americans don't have to wait until they're retired to know that Social Security benefits won't be enough to maintain their current lifestyle. If they pay any attention to retirement planning
Cigna Group (CI) Q1 2023 Earnings Call Transcript
Image source: The Motley Fool.
Cigna Group (NYSE: CI)Q1 2023 Earnings CallMay 05, 2023, 8:30 a.m. ET
Operator
Source Fool.com
2 Magnificent Dividend Stocks to Buy Before the Next Recession
Fears of a coming recession are probably about as high right now as they have been over the past year. That's because the U.S. Federal Reserve recently predicted an economic downturn would descend
Vaccine Sales Are Falling. Should You Still Buy Pfizer?
Pfizer (NYSE:PFE) confirmed this week what everyone has been expecting. COVID-19 vaccine sales are falling drastically. The company reported a 77% drop in Comirnaty sales in the first quarter
Why Regeneron Pharmaceuticals Stock Is Tanking Today
Regeneron Pharmaceuticals (NASDAQ: REGN), a large-cap biotechnology company, is under heavy pressure today. Specifically, the biotech's stock was down by an unsightly 6.5% on heavy volume as of
Zoetis (ZTS) Q1 2023 Earnings Call Transcript
Image source: The Motley Fool.
Zoetis (NYSE: ZTS)Q1 2023 Earnings CallMay 04, 2023, 8:30 a.m. ET
Operator
Source Fool.com
2 High-Yielding Dividend Stocks Analysts Expect Will Rise by at Least 50%
Investors often gloss over dividend stocks, assuming that they offer nothing more than a recurring payout. But there are a couple of stocks that analysts are bullish about and that they believe
2 Potentially Explosive Stocks to Buy in May
Stag Industrial (NYSE: STAG) and Vertex Pharmaceuticals (NASDAQ: VRTX) are off to a good start this year, and some industry tailwinds look to really boost shares in the coming years. Stag, which
3 Top Healthcare Stocks to Buy in May
Healthcare stocks always make a great addition to long-term portfolios. They offer you the potential to benefit from steady earnings growth over time. After all, regardless of the economic
Why Amgen Stock Was Sickly Today
Investors are often encouraged when one of their companies bulks up by acquiring a peer. But that sentiment can turn sour if the takeover target stumbles.
This was the impetus behind Amgen's
2 Things About AbbVie That Investors Are Ignoring
Investors were ready for declines in AbbVie's (NYSE: ABBV) blockbuster immunology drug Humira. The product now is facing competition in the U.S. So, seeing a 26% drop in Humira's U.S. first-quarter
Why Eli Lilly Stock Is Bolting Higher Today
Shares of the Illinois-based drugmaker Eli Lilly (NYSE: LLY) were up by 6% on heavy volume as of 1:45 p.m. ET Wednesday.
What sparked this latest rally? Ahead of the opening bell, Lilly announced
Is This Incredibly Cheap, High-Yield Dividend Stock a Screaming Buy After Q1 Earnings?
High-quality dividend stocks are normally a great addition to any portfolio regardless of market conditions. However, this exceedingly risk-averse market has punished even elite dividend-paying